{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T13:18:53Z","timestamp":1779110333774,"version":"3.51.4"},"reference-count":17,"publisher":"The Japanese Society for Medical Mycology","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Mycology Journal"],"published-print":{"date-parts":[[2016]]},"DOI":"10.3314\/mmj.57.j19","type":"journal-article","created":{"date-parts":[[2016,2,29]],"date-time":"2016-02-29T17:09:14Z","timestamp":1456765754000},"page":"J19-J25","source":"Crossref","is-referenced-by-count":5,"title":["Distribution of Luliconazole in Nail Plate by &lt;I&gt;In Vitro&lt;\/I&gt; Permeation and Efficacy by Zone of Inhibition Test after Treatment of Luliconazole Nail Solution"],"prefix":"10.3314","volume":"57","author":[{"given":"Tsuyoshi","family":"Shimamura","sequence":"first","affiliation":[{"name":"R&D Laboratories, POLA PHARMA INC."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Miyamae","sequence":"additional","affiliation":[{"name":"R&D Laboratories, POLA PHARMA INC."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakazu","family":"Arai","sequence":"additional","affiliation":[{"name":"R&D Laboratories, POLA PHARMA INC."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aya","family":"Minemura","sequence":"additional","affiliation":[{"name":"R&D Laboratories, POLA PHARMA INC."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Nozawa","sequence":"additional","affiliation":[{"name":"R&D Laboratories, POLA PHARMA INC."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuo","family":"Kubota","sequence":"additional","affiliation":[{"name":"R&D Laboratories, POLA PHARMA INC."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1842","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Pires CAA, Cruz NF, Lobato AM, Sousa PO, Carneiro FR, Mendes AM : Clinical, epidemiological, and therapeutic profile of dermatophytosis. An Bras Dermatol 89 : 259-264, 2014.","DOI":"10.1590\/abd1806-4841.20142569"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Panackal AA, Halpern EF, Watson AJ : Cutaneous fungal infections in the United States : Analysis of the National Ambulatory Medical Care Survey (NAMCS) and National Hospital Ambulatory Medical Care Survey (NHAMCS), 1995-2004. Int J Dermatol 48 : 704-712, 2009.","DOI":"10.1111\/j.1365-4632.2009.04025.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Ghannoum MA, Hajjeh RA, Scher R, Konnikov N, Gupta AK, Summerbell R, Sullivan S, Daniel R, Krusinski P, Fleckman P, Rich P, Odom R, Aly R, Pariser D, Zaiac M, Rebell G, Lesher J, Gerlach B, Ponce-De-Leon GF, Ghannoum A, Warner J, Isham N, Elewski B : A large-scale North American study of fungal isolates from nails : the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns. J Am Acad Dermatol 43 : 641-648, 2000.","DOI":"10.1067\/mjd.2000.107754"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Ogasawara Y : Prevalence and patient&rsquo;s consciousness of tinea pedis and onychomycosis. Jpn J Med Mycol 44 : 253-260, 2003.","DOI":"10.3314\/jjmm.44.253"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Haneke E, Roseeuw D : The scope of onychomycosis : epidemiology and clinical features. Int J Dermatol 38 (Suppl 2) : 7-12, 1999.","DOI":"10.1046\/j.1365-4362.1999.00015.x"},{"key":"6","unstructured":"7) Daniel RC : Onychomycosis : burden of disease and the role of topical antifungal treatment. J Drugs Dermatol 12 : 1263-1266, 2013."},{"key":"7","unstructured":"8) Elewski B, Tavakkol A : Safety and tolerability of oral antifungal agents in the treatment of fungal nail disease : a proven reality. Ther Clin Risk Manag 1 : 299-306, 2005."},{"key":"8","doi-asserted-by":"crossref","unstructured":"9) Saner MV, Kulkarni AD, Pardeshi CV : Insights into drug delivery across the nail plate barrier. J Drug Target 22 : 769-789, 2014.","DOI":"10.3109\/1061186X.2014.929138"},{"key":"9","doi-asserted-by":"crossref","unstructured":"10) Khengar RH, Jones SA, Turner RB, Forbes B, Brown MB : Nail swelling as a pre-formulation screen for the selection and optimisation of ungual penetration enhancers. Pharm Res 24 : 2207-2212, 2007.","DOI":"10.1007\/s11095-007-9368-3"},{"key":"10","doi-asserted-by":"crossref","unstructured":"11) Elewski BE : Onychomycosis : pathogenesis, diagnosis, and management. Clin Microbiol Rev 11 : 415-429, 1998.","DOI":"10.1128\/CMR.11.3.415"},{"key":"11","doi-asserted-by":"crossref","unstructured":"12) E.J van Hoogdalem, W.E van den Hoven, I.J Terpstra, J van Zijtveld, J.S.C Verschoor, J.N Visser : Nail penetration of the antifungal agent oxiconazole after repeated topical application in healthy volunteers, and the effect of acetylcysteine. Eur J Pharm Sci 5 : 119-127, 1997.","DOI":"10.1016\/S0928-0987(97)00270-4"},{"key":"12","doi-asserted-by":"crossref","unstructured":"13) Gupta AK, Daigle D, Paquet M : Therapies for onychomycosis : a systematic review and network meta-analysis of mycological cure. J Am Podiatr Med Assoc 105 : 357-366, 2015.","DOI":"10.7547\/13-110.1"},{"key":"13","unstructured":"14) Gupta AK, Cvetkovi&cacute; D, Abramovits W, Vincent KD: LUZU (luliconazole) 1% cream. Skinmed 12 : 90-93, 2014."},{"key":"14","doi-asserted-by":"crossref","unstructured":"15) Uchida K, Nishiyama Y, Yamaguchi H : <I>In vitro<\/I> antifungal activity of luliconazole (NND-502), a novel imidazole antifungal agent. J Infect Chemother 10 : 216-219, 2004.","DOI":"10.1007\/s10156-004-0327-1"},{"key":"15","doi-asserted-by":"crossref","unstructured":"16) Koga H, Tsuji Y, Inoue K, Kanai K, Majima T, Kasai T, Uchida K, Yamaguchi H : <I>In vitro<\/I> antifungal activity of luliconazole against clinical isolates from patients with dermatomycoses. J Infect Chemother 12 : 163-165, 2006.","DOI":"10.1007\/s10156-006-0440-4"},{"key":"16","doi-asserted-by":"crossref","unstructured":"17) Koga H, Nanjoh Y, Makimura K, Tsuboi R : <I>In vitro<\/I> antifungal activities of luliconazole, a new topical imidazole. Med Mycol 47 : 640-647, 2009.","DOI":"10.1080\/13693780802541518"},{"key":"17","doi-asserted-by":"crossref","unstructured":"18) Roderick J Hay, Robert Baran : Fungal (Onychomycosis) and other infections involving the nail apparatus. <I>In<\/I> In Baran and Dawber&rsquo;s Diseases of the Nails and their Management 4th ed (Baran R, de Berker DAR, Holzberg M, Thomas L ed), chapter 5, pp. 211-255, A John Wiley and Son&rsquo;s, Ltd., Chichester, 2012.","DOI":"10.1002\/9781118286715.ch5"}],"container-title":["Medical Mycology Journal"],"original-title":["\u30eb\u30ea\u30b3\u30ca\u30be\u30fc\u30eb\u722a\u5916\u7528\u6db2\u306e&lt;I&gt;in vitro&lt;\/I&gt;\u722a\u900f\u904e\u6027\u8a66\u9a13\u304a\u3088\u3073\u30b9\u30e9\u30a4\u30b9\u963b\u6b62\u5186\u6cd5\u306b\u3088\u308b\u722a\u4e2d\u85ac\u7269\u6fc3\u5ea6\u5206\u5e03\u304a\u3088\u3073\u6297\u771f\u83cc\u6d3b\u6027\u8a55\u4fa1"],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/mmj\/57\/1\/57_J19\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T23:53:45Z","timestamp":1567641225000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/mmj\/57\/1\/57_J19\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.3314\/mmj.57.j19","relation":{},"ISSN":["2185-6486","2186-165X"],"issn-type":[{"value":"2185-6486","type":"print"},{"value":"2186-165X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}